---

October 13, 2025

Predictmedix AI Announces Multi-Vertical Growth Strategy to Become an AI Health-Technology Leader

What is a neural network? Neural networks are inspired by the structure and functioning of the human brain. The brain is composed of neurons, which communicate with each other through synapses. Similarly, neural networks consist…

Read full release →

October 13, 2025

Predictmedix AI Announces Multi-Vertical Growth Strategy to Become an AI Health-Technology Leader

Clinically validated SmartHealth AI Stations anchor expansion into Clinical-Trial Optimization and Consumer Digital Health, creating multiple recurring-revenue opportunities TORONTO-Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP0) (“Predictmedix” or the “Company”), an emerging leader in…

Read full release →

October 13, 2025

Predictmedix AI to Present at the 25th MK Investment Conference in Munich, Germany

TORONTO–Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP0) (“Predictmedix” or the “Company”), an emerging leader in AI-powered health and safety technology, is pleased to announce that its Chief Operating Officer and Co-founder, Dr. Rahul…

Read full release →

October 01, 2025

Predictmedix launches clinical trial AI platform

Dr. Rahul Kushwah reports PREDICTMEDIX AI LAUNCHES NEXT-GENERATION CLINICAL-TRIAL AI PLATFORM Predictmedix AI Inc. has launched its clinical trial artificial intelligence platform, an artificial-intelligence-driven solution intended to help pharmaceutical sponsors and contract research organizations model,…

Read full release →

October 01, 2025

Predictmedix AI Launches Next-Generation Clinical-Trial AI Platform

Adaptive “digital brain” designed to cut risk, cost and timelines in the $70-billion clinical-trials market1 Toronto, Ontario–(Newsfile Corp. – October 1, 2025) – Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) (“Predictmedix” or…

Read full release →